[Form 4] Global Medical REIT Inc. Insider Trading Activity

Rhea-AI Filing Summary

Jamie Allen Barber, who serves as General Counsel and Secretary and is identified as a director, reported the sale of 130,000 shares of Global Medical REIT Inc. (GMRE) on 08/15/2025. The Form 4 shows the shares were sold at a weighted average price of $6.6236 (individual trade prices ranged from $6.50 to $6.74). Following the reported transactions the filing indicates 0 shares beneficially owned by the reporting person. The form was signed on 08/18/2025 and was filed by one reporting person.

Positive

• Form filed with required details: includes transaction date, share amount, price range, weighted average price, and signature
• Transparency on trade pricing: provides weighted average price and range ($6.50–$6.74) and offers to supply per-trade details upon request

Negative

• Complete disposition by an officer/director: sale of 130,000 shares reduced beneficial ownership to 0 shares
• Insider exit from equity could be viewed unfavorably by some investors given the reporting person’s officer/director status

Insights

Securities Analyst

TL;DR: Insider sold all reported holdings—130,000 shares—at a weighted average of $6.6236, reducing beneficial ownership to zero.

The sale of 130,000 shares by a named officer and director is a clear disclosure event for investors and compliance monitors. The Form 4 provides precise trade range ($6.50–$6.74) and the weighted average price, which enables assessment of gross proceeds from the disposition. Because the filing discloses post-transaction beneficial ownership of zero, this removes this individual from insider equity exposure until any future filings disclose acquisitions.

Corporate Governance Expert

TL;DR: Filing is complete and timely; it documents an officer/director exit from equity ownership through multiple sales.

The Form 4 appears properly completed: it identifies the reporting person, relationship to the issuer, transaction date, aggregate shares sold, price range with weighted average, and a manual signature dated three days after the transaction. From a governance and disclosure standpoint, the document satisfies Section 16 reporting by showing the officer/director disposition and post-sale ownership of zero, but it does not provide any plan or reason for the sales within the filing itself.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Barber Jamie Allen

(Last) (First) (Middle)

7373 WISCONSIN AVENUE, SUITE 800

(Street)

BETHESDA MD 20814

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Global Medical REIT Inc. [ GMRE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel and Secretary

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		S		130,000	D	$6.6236(1)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This is the weighted average price. Shares were sold in multiple transactions at prices ranging from $6.50 to $6.74. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The amount reflected has been rounded to four decimal points.

	/s/ Jamie Barber	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Jamie Allen Barber disclose on the Form 4 for GMRE?

Barber disclosed a sale of 130,000 shares of Global Medical REIT Inc. on 08/15/2025 at a weighted average price of $6.6236, with prices ranging $6.50–$6.74.

How many GMRE shares does the reporting person own after the transaction?

0 shares beneficially owned following the reported transactions, per the Form 4.

When was the Form 4 signed and filed?

Signed on 08/18/2025; the transaction date reported is 08/15/2025 and the form indicates it was filed by one reporting person.

What was the sale price per share on the Form 4 for GMRE?

Weighted average price $6.6236; individual trade prices ranged from $6.50 to $6.74 as noted in the footnote.

What is the reporting person’s role at GMRE as listed on the form?

General Counsel and Secretary, and the form also indicates director status.

Does the Form 4 state why the shares were sold?

No—the filing reports the transactions and prices but does not provide a reason for the sales.